Application of nisin as a potential drug candidate for electrochemotherapy.
Saved in:
| Title: | Application of nisin as a potential drug candidate for electrochemotherapy. |
|---|---|
| Authors: | Michel O; Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wrocław, Poland.; Department of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania., Lekešytė B; Department of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania.; Faculty of Electronics, Vilnius Gediminas Technical University, Vilnius, Lithuania., Malyško-Ptašinskė V; Department of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania.; Faculty of Electronics, Vilnius Gediminas Technical University, Vilnius, Lithuania., Morozas A; Department of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania., Malakauskaitė P; Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wrocław, Poland.; Department of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania.; Faculty of Electronics, Vilnius Gediminas Technical University, Vilnius, Lithuania., Mickevičiūtė-Zinkuvienė E; Department of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania.; Faculty of Electronics, Vilnius Gediminas Technical University, Vilnius, Lithuania., Želvys A; Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wrocław, Poland.; Department of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania.; Faculty of Electronics, Vilnius Gediminas Technical University, Vilnius, Lithuania., Ivaška J; Department of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania.; Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Kulbacka J; Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wrocław, Poland.; Department of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania., Novickij V; Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wrocław, Poland.; Department of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania.; Faculty of Electronics, Vilnius Gediminas Technical University, Vilnius, Lithuania. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Nov 28; Vol. 15, pp. 1689261. Date of Electronic Publication: 2025 Nov 28 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1689261 |
